# Universal Corp: overview

UVV · NYSE · CIK 102037 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/uvv.md) · [Financials](/companies/uvv/financials.md) · [Filings](/companies/uvv/filings.md) · [Insiders](/companies/uvv/insiders.md)

Latest reported revenue: [$520.3m](/filings/0001628280-26-053393.md) for Q1 FY2027, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-053393).

## Last eight quarters

| Line item | Unit | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [708](/filings/0001628280-25-049596.md) | [928](/filings/0001628280-26-006203.md) | [690 d](/filings/0001628280-26-039511.md) | [593](/filings/0001628280-26-053393.md) | [749](/filings/0001628280-25-049596.md) | [853](/filings/0001628280-26-006203.md) | [690 d](/filings/0001628280-26-039511.md) | [520](/filings/0001628280-26-053393.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [9.7%](/filings/0001628280-25-049596.md) | [11.2%](/filings/0001628280-26-006203.md) | [6.2% d](/filings/0001628280-26-039511.md) | [5.7%](/filings/0001628280-26-053393.md) | [9.0%](/filings/0001628280-25-049596.md) | [9.6%](/filings/0001628280-26-006203.md) | [(2.2%) d](/filings/0001628280-26-039511.md) | [0.4%](/filings/0001628280-26-053393.md) |
| Net margin | % | [3.7%](/filings/0001628280-25-049596.md) | [6.4%](/filings/0001628280-26-006203.md) | [1.4% d](/filings/0001628280-26-039511.md) | [1.4%](/filings/0001628280-26-053393.md) | [4.6%](/filings/0001628280-25-049596.md) | [3.9%](/filings/0001628280-26-006203.md) | [(6.3%) d](/filings/0001628280-26-039511.md) | [(1.0%)](/filings/0001628280-26-053393.md) |
| Diluted EPS | $ per share | [1.03](/filings/0001628280-25-049596.md) | [2.37](/filings/0001628280-26-006203.md) | not reported | [0.34](/filings/0001628280-26-053393.md) | [1.36](/filings/0001628280-25-049596.md) | [1.32](/filings/0001628280-26-006203.md) | not reported | [(0.20)](/filings/0001628280-26-053393.md) |
| Free cash flow | $m | [(1.0) d](/filings/0001628280-25-049596.md) | [200 d](/filings/0001628280-26-006203.md) | [151 d](/filings/0001628280-26-039511.md) | [(217)](/filings/0001628280-26-053393.md) | [23.7 d](/filings/0001628280-25-049596.md) | [95.1 d](/filings/0001628280-26-006203.md) | [179 d](/filings/0001628280-26-039511.md) | [(133)](/filings/0001628280-26-053393.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,091](/filings/0000102037-25-000017.md) | [2,550](/filings/0000102037-25-000028.md) | [2,722](/filings/0001628280-26-039511.md) | [2,923](/filings/0001628280-26-039511.md) | [2,885](/filings/0001628280-26-039511.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [7.7%](/filings/0000102037-25-000017.md) | [7.1%](/filings/0000102037-25-000028.md) | [8.2%](/filings/0001628280-26-039511.md) | [8.0%](/filings/0001628280-26-039511.md) | [5.8%](/filings/0001628280-26-039511.md) |
| Net margin | % | [4.1%](/filings/0000102037-25-000017.md) | [4.9%](/filings/0000102037-25-000028.md) | [4.4%](/filings/0001628280-26-039511.md) | [3.3%](/filings/0001628280-26-039511.md) | [1.1%](/filings/0001628280-26-039511.md) |
| Diluted EPS | $ per share | [3.47](/filings/0000102037-25-000017.md) | [4.97](/filings/0000102037-25-000028.md) | [4.78](/filings/0001628280-26-039511.md) | [3.78](/filings/0001628280-26-039511.md) | [1.30](/filings/0001628280-26-039511.md) |
| Free cash flow | $m | [(8.3)](/filings/0000102037-25-000017.md) | [(65.2)](/filings/0000102037-25-000028.md) | [(141)](/filings/0001628280-26-039511.md) | [264](/filings/0001628280-26-039511.md) | [80.3](/filings/0001628280-26-039511.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/uvv/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $203.2m | 3,895,750 |  | Added +87,864 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $94.5m | 1,811,024 |  | Added +68,498 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $92.1m | 1,764,415 |  | Reduced −10,442 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $75.6m | 1,449,407 |  | Added +50,989 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $58.2m | 1,115,922 |  | Added +47,927 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $39.3m | 752,733 |  | Reduced −74,646 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $33.8m | 648,150 |  | Added +44,460 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $22.2m | 424,680 |  | Reduced −53,345 |
| [PRUDENTIAL FINANCIAL INC](/funds/1137774.md) | 2026-06-30 | $21.0m | 402,344 |  | Reduced −7,613 |
| [FIRST TRUST ADVISORS LP](/funds/1125816.md) | 2026-06-30 | $20.4m | 391,184 |  | Added +37,529 |

## Recent filings

[All 1,376 filings](/companies/uvv/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 20:23 ET | [8-K](/filings/0001193125-26-420470.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-420470 |
| 2026-09-18 | 20:15 ET | [8-K](/filings/0001193125-26-395560.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-395560 |
| 2026-08-05 | 20:19 ET | [10-Q](/filings/0001628280-26-053393.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053393 |
| 2026-08-05 | 20:18 ET | [8-K](/filings/0001628280-26-053392.md) | 2.02 Results of operations; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-053392 |
| 2026-08-04 | 20:30 ET | [8-K](/filings/0001193125-26-332942.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-332942 |
| 2026-07-01 | 21:35 ET | [DEF 14A](/filings/0001628280-26-046310.md) | Proxy statement, period 2026-03-31 | 0001628280-26-046310 |
| 2026-06-01 | 20:20 ET | [10-K](/filings/0001628280-26-039511.md) | Annual report, period 2026-03-31 | 0001628280-26-039511 |
| 2026-05-28 | 20:16 ET | [8-K](/filings/0001628280-26-038822.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-038822 |
| 2026-03-16 | 10:01 ET | [8-K/A](/filings/0001193125-26-107071.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-107071 |
| 2026-02-09 | 13:16 ET | [10-Q](/filings/0001628280-26-006203.md) | Quarterly report, period 2025-12-31 | 0001628280-26-006203 |

## Latest annual report

[Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0001628280-26-039511.md), filed Jun 1, 2026.

## Forecast league

Q2 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/b4e4c7a7-eb9b-45e2-b7aa-c22d0741e9e0)

## About the filer

- CIK: 102037
- Tickers: UVV
- Exchange: NYSE
- SIC code: 5150 Wholesale-Farm Product Raw Materials
- State of incorporation: VA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.